Recent research has identified that at least 7 of these sPLA2s modulate glucose metabolism, presumably by generation of fatty acids or lipoproteins that influence lipid metabolism and mobilization, alterations in fatty acid oxidation, or other mechanisms involved in insulin signaling and obesity (Table 1). The gene discussed is INS; the disease is Obesity.